73,833 Shares in Cigna Group $CI Acquired by Kiltearn Partners LLP

Key Points

• Kiltearn Partners acquired 73,833 Cigna shares worth approximately $20.4 million, making Cigna its seventh-largest portfolio holding at about 4.9%. Institutional investors own nearly 87% of the company.
• Cigna exceeded quarterly earnings expectations, reporting $7.78 in EPS versus the $7.60 consensus, while revenue rose 6.7% year over year to $70.04 billion. The company also announced a quarterly dividend of $1.56 per share, representing a 2.3% yield.
• Analyst sentiment remains positive overall, with a consensus “Moderate Buy” rating and a $339.45 price target, although some firms recently downgraded the stock to “Hold.” Cigna shares opened at $276.19, while insiders have sold more than 23,000 shares over the past three months.

Kiltearn Partners LLP acquired a new stake in shares of Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 73,833 shares of the health services provider's stock, valued at approximately $20,354,000. Cigna Group makes up about 4.9% of Kiltearn Partners LLP's portfolio, making the stock its 7th biggest position.

Other large investors also recently added to or reduced their stakes in the company. Evercore Wealth Management LLC increased its stake in shares of Cigna Group by 2.8% during the 1st quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider's stock worth $347,000 after purchasing an additional 35 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its stake in shares of Cigna Group by 11.0% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider's stock valued at $100,000 after purchasing an additional 36 shares during the last quarter. OLD National Bancorp IN lifted its stake in shares of Cigna Group by 3.7% in the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider's stock valued at $284,000 after purchasing an additional 37 shares during the last quarter. IHT Wealth Management LLC boosted its holdings in Cigna Group by 2.5% in the fourth quarter. IHT Wealth Management LLC now owns 1,535 shares of the health services provider's stock worth $423,000 after purchasing an additional 38 shares in the last quarter. Finally, Whetstone Capital Advisors LLC boosted its holdings in Cigna Group by 4.9% in the fourth quarter. Whetstone Capital Advisors LLC now owns 829 shares of the health services provider's stock worth $228,000 after purchasing an additional 39 shares in the last quarter. 86.99% of the stock is owned by institutional investors.

Cigna Group Price Performance

Shares of NYSE:CI opened at $276.19 on Friday. The company has a market cap of $72.98 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.95 and a beta of 0.29. The business has a 50 day moving average price of $284.20 and a 200 day moving average price of $281.38. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts' consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The company had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same period in the previous year, the company earned $7.20 earnings per share. The company's quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group's dividend payout ratio is presently 25.82%.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 2,677 shares of the business's stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares in the company, valued at approximately $7,236,306.80. The trade was a 9.37% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company's stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

CI has been the topic of several analyst reports. Barclays raised their target price on Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. Jefferies Financial Group downgraded Cigna Group from a "buy" rating to a "hold" rating and decreased their price target for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Wells Fargo & Company increased their price objective on Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a report on Friday, July 31st. UBS Group raised their price objective on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a research note on Friday, May 22nd. Finally, Wall Street Zen cut Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st. Fifteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.

About Cigna Group

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source